About This Recruitment / Exam
The Union Public Service Commission conducts recruitment examinations to select qualified professionals for critical civil services and central administrative positions across India. Additionally, specialized central health institutions like the Employees State Insurance Corporation operate under statutory mandates to deliver comprehensive medical care, essential pharmaceutical services, and specialized healthcare infrastructure to millions of registered industrial workers and their dependent families nationwide.
Pharmacology forms the absolute core foundation of competitive government pharmacist recruitment examinations conducted regularly by prominent institutions such as the Railway Recruitment Board, ESIC, and AIIMS CRE Grade-II. Mastering precise drug classifications and intricate mechanisms of action is fundamentally essential for candidates to accurately tackle complex multiple-choice questions regarding precise therapeutic indications, major drug interactions, and unexpected adverse drug reactions during high-stakes tests.
Aspirants must possess a recognized diploma or degree in pharmacy alongside valid state registration to clear the rigorous selection process, which typically features objective computer-based tests evaluating technical expertise. Candidates must thoroughly understand pharmacodynamics, pharmacokinetic parameters, and targeted receptor pathways because competitive pharmacy exams increasingly emphasize clinical application scenarios rather than rote memorization, requiring deep analytical comprehension of drug classes.
To secure top ranks, candidates should systematically utilize high-yield master tables, consistently solve previous years question papers, and practice targeted multiple-choice questions daily under simulated exam conditions. Reviewing official notifications promptly on authorized government job portals ensures applicants complete registration without delays, while disciplined revision schedules guarantee comprehensive syllabus coverage before the recruitment test date arrives.
Pharmacology forms the core foundation of competitive government pharmacist recruitment examinations conducted by institutions like the Railway Recruitment Board, ESIC, and AIIMS CRE Grade-II. Mastering drug classifications and mechanisms of action is essential for candidates to tackle complex multiple-choice questions regarding therapeutic indications, adverse drug reactions, and molecular receptor targets effectively.
This master guide provides a comprehensive pharmacology table detailing high-yield drug classifications and mechanisms of action tailored specifically for upcoming 2026 pharmacist exams. Review the complete classification breakdown, target receptors, and pharmacological actions below to strengthen your preparation and secure a high score in your examination.
| Subject / Topic : | Pharmacology Master Classifications, Receptor Targets & Mechanisms of Action (MOA) Table |
| Target Examinations : | Railway RRB Pharmacist (CEN 05/2026), ESIC, AIIMS CRE Grade-II, DSSSB Delhi, UPSSSC, CGHS & State PSC Exams |
| Format & Category : | Scientific Reference Tables, Prototype Drugs, Mechanism of Action (MOA) & High-Yield Exam Points |
| Short Summary : | Pharmacology accounts for 25% to 35% of all technical domain questions in All-India Government Pharmacist recruitment examinations. This master study compilation brings together official drug classifications, biochemical mechanisms of action (MOA), receptor-level targets, prototype compounds, and critical adverse effect pearls across ANS, CVS, CNS, Antimicrobials, Endocrine, and GIT systems. |
| High-Yield Pharmacology Quick Reference Grid | |
|---|---|
| Core Physiological Systems: ANS, CVS, CNS, Renal, Endocrine & Chemotherapy | Total Prototype Drugs Covered: 120+ High-Yield Compounds |
| Weightage in RRB / ESIC Exams: 25 – 35 Marks (Pharmacy Domain) | Standard Reference Framework: PCI Education Regulations & Indian Pharmacopoeia |
| Section 1: Autonomic Nervous System (ANS) — Classifications & MOA | |||
|---|---|---|---|
| Drug Class | Prototype Drugs | Mechanism of Action (MOA) | High-Yield Exam Pearl |
| Direct Cholinergic Agonists | Pilocarpine, Bethanechol, Carbachol | Directly stimulate muscarinic receptors (M1, M2, M3), mimicking acetylcholine. | Pilocarpine causes miosis; used in open-angle glaucoma. Bethanechol treats urinary retention. |
| Reversible Anticholinesterases | Neostigmine, Physostigmine, Pyridostigmine, Edrophonium, Donepezil | Reversibly inhibit Acetylcholinesterase (AChE), prolonging acetylcholine at neuromuscular junctions. | Physostigmine is tertiary amine (crosses BBB) → antidote for Atropine poisoning. Edrophonium used in Tensilon test for Myasthenia Gravis. |
| Anticholinergics (Antimuscarinic) | Atropine, Hyoscine (Scopolamine), Ipratropium, Tiotropium, Glycopyrrolate | Competitive antagonism of muscarinic acetylcholine receptors (M1, M2, M3). | Atropine is specific antidote for Organophosphate / Carbamate insecticide poisoning. Hyoscine used for motion sickness. |
| Beta-2 Adrenergic Agonists | Salbutamol (Albuterol), Terbutaline, Salmeterol, Formoterol | Selectively stimulate Beta-2 receptors → activates adenylyl cyclase → ↑ cAMP → bronchodilation. | Drug of choice in acute bronchial asthma attacks. Common side effect: muscle tremors & tachycardia. |
| Alpha-1 Adrenergic Blockers | Prazosin, Terazosin, Tamsulosin, Doxazosin | Selective blockade of vascular Alpha-1 receptors → vasodilation and relaxation of bladder neck smooth muscle. | Prazosin causes ‘First-Dose Syncope’ (postural hypotension). Tamsulosin is Alpha-1A selective for BPH without severe hypotension. |
| Beta Blockers (Non-Selective & Cardioselective) | Propranolol (Beta-1 & Beta-2), Atenolol, Metoprolol (Beta-1 selective) | Block Beta-1 receptors → decrease heart rate, myocardial contractility, and renin release from juxtaglomerular cells. | Propranolol is contraindicated in bronchial asthma patients (causes severe bronchospasm via Beta-2 blockade). |
| Section 2: Cardiovascular System (CVS) — Antihypertensives & Diuretics | |||
|---|---|---|---|
| Drug Class | Prototype Drugs | Mechanism of Action (MOA) | High-Yield Exam Pearl |
| ACE Inhibitors | Captopril, Enalapril, Ramipril, Lisinopril | Inhibit Angiotensin-Converting Enzyme (ACE) → prevent conversion of Angiotensin I to II → ↓ aldosterone; prevent bradykinin degradation. | Persistent dry cough and angioedema caused by bradykinin accumulation. Contraindicated in pregnancy (teratogenic). |
| Angiotensin Receptor Blockers (ARBs) | Losartan, Telmisartan, Valsartan, Candesartan | Competitive blockade of Angiotensin II Type-1 (AT1) receptors on blood vessels and adrenal cortex. | Alternative for patients who develop dry cough on ACE inhibitors (does not inhibit bradykinin breakdown). |
| Calcium Channel Blockers (CCBs) | Amlodipine, Nifedipine (DHPs), Verapamil, Diltiazem (Non-DHPs) | Block L-type voltage-gated Ca2+ channels in vascular smooth muscle and cardiac myocytes → vasodilation & ↓ contractility. | Amlodipine causes peripheral ankle edema. Verapamil causes constipation and should not be combined with Beta blockers (severe bradycardia/AV block). |
| Loop Diuretics (High Ceiling) | Furosemide, Torsemide, Bumetanide | Inhibit Na+/K+/2Cl- symporter in the thick ascending limb of Henle’s loop. | Causes hypokalemia, hyponatremia, hyperuricemia, and ototoxicity (especially when given with aminoglycosides). |
| Thiazide Diuretics | Hydrochlorothiazide, Chlorthalidone | Inhibit Na+/Cl- cotransporter in the early distal convoluted tubule (DCT). | Causes hypercalcemia (enhances Ca2+ reabsorption); first-line drug in uncomplicated hypertension. |
| Potassium-Sparing Diuretics | Spironolactone, Eplerenone, Amiloride, Triamterene | Spironolactone competitively antagonizes aldosterone receptors; Amiloride directly blocks epithelial Na+ channels (ENaC). | Spironolactone causes gynecomastia (antiandrogenic effect) and risk of hyperkalemia. |
| Organic Nitrates | Nitroglycerin (GTN), Isosorbide Dinitrate, Isosorbide Mononitrate | Denitrated to release Nitric Oxide (NO) → stimulates guanylyl cyclase → ↑ cGMP → vascular smooth muscle relaxation (venodilation). | Sublingual GTN bypasses extensive first-pass hepatic metabolism. Contraindicated with Sildenafil / PDE-5 inhibitors (severe fatal hypotension). |
| HMG-CoA Reductase Inhibitors (Statins) | Atorvastatin, Rosuvastatin, Simvastatin | Competitively inhibit rate-limiting enzyme 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase in liver. | Major adverse effects: Myopathy and Rhabdomyolysis. Must monitor serum creatine kinase (CK) and liver enzymes. |
| Section 3: Central Nervous System (CNS) — Sedatives, Antiepileptics & Analgesics | |||
|---|---|---|---|
| Drug Class | Prototype Drugs | Mechanism of Action (MOA) | High-Yield Exam Pearl |
| Benzodiazepines (BZDs) | Diazepam, Lorazepam, Alprazolam, Clonazepam | Positive allosteric modulators of GABA-A receptors → increase the FREQUENCY of chloride channel opening. | Specific antidote for BZD overdose: Flumazenil (competitive antagonist at BZD binding site). |
| Barbiturates | Phenobarbital, Thiopental sodium | Increase the DURATION of GABA-A chloride channel opening; directly open Cl- channels at high concentrations. | Thiopental is ultra-short acting due to rapid redistribution into skeletal muscle and adipose tissue. Phenobarbital is a potent CYP450 inducer. |
| Hydantoin Anticonvulsants | Phenytoin (Diphenylhydantoin) | Prolongs the inactivated state of voltage-gated Na+ channels, suppressing high-frequency neuronal firing. | Exhibits zero-order kinetics at therapeutic levels. Classic side effects: Gingival hyperplasia, hirsutism, megaloblastic anemia, osteomalacia. |
| Succinimides (Anti-Absence) | Ethosuximide | Blocks low-threshold T-type Ca2+ channels in thalamic relay neurons. | Drug of choice for Absence (Petit Mal) Seizures in children. |
| Opioid Analgesics | Morphine, Fentanyl, Pethidine, Codeine | Agonists at Mu (μ), Kappa (κ), and Delta (δ) G-protein coupled opioid receptors → close Ca2+ channels & open K+ channels. | Classic triad of poisoning: Pinpoint pupils (miosis), respiratory depression, coma. Specific antidote: Naloxone (IV). |
| Section 4: Antimicrobial Agents & Chemotherapy | |||
|---|---|---|---|
| Antibiotic Class | Prototype Drugs | Target & Mechanism of Action | High-Yield Exam Pearl |
| Beta-Lactams (Penicillins & Cephalosporins) | Amoxicillin, Benzylpenicillin, Ceftriaxone, Cefotaxime | Inhibit bacterial cell wall synthesis by binding to Penicillin-Binding Proteins (PBPs) and blocking transpeptidase cross-linking of peptidoglycan. | Clavulanic acid and Tazobactam are Beta-lactamase (penicillinase) inhibitors added to restore activity against resistant strains. |
| Aminoglycosides | Gentamicin, Amikacin, Streptomycin, Tobramycin | Irreversibly bind to 30S bacterial ribosomal subunit → misreading of genetic code → bactericidal protein synthesis inhibition. | Narrow therapeutic index. Dose-dependent Ototoxicity (vestibular/cochlear damage) and Nephrotoxicity. Streptomycin is used in TB regimen. |
| Macrolides | Azithromycin, Clarithromycin, Erythromycin | Reversibly bind to 50S bacterial ribosomal subunit → inhibit translocation step of protein synthesis (bacteriostatic). | Safe alternative in penicillin-allergic patients. Erythromycin is a potent CYP3A4 inhibitor and causes QT-interval prolongation. |
| Fluoroquinolones | Ciprofloxacin, Levofloxacin, Ofloxacin | Inhibit bacterial DNA Gyrase (Topoisomerase II) and Topoisomerase IV → block DNA replication and repair. | Adverse effect: Tendonitis and Tendon rupture (Achilles tendon). Contraindicated in growing children due to cartilage damage (arthropathy). |
| Tetracyclines | Doxycycline, Oxytetracycline, Minocycline | Reversibly bind to 30S ribosomal subunit → prevent attachment of aminoacyl-tRNA to acceptor (A) site. | Chelates divalent cations (Ca2+, Mg2+, Fe2+) → causes permanent yellow-brown tooth discoloration and enamel hypoplasia in children under 8 years. |
| Glycopeptides | Vancomycin, Teicoplanin | Binds directly to D-Ala-D-Ala terminus of cell wall peptidoglycan precursors → inhibits transglycosylation. | Drug of choice for Methicillin-Resistant Staphylococcus aureus (MRSA). Rapid IV infusion causes ‘Red Man Syndrome’ (histamine release). |
| Section 5: Gastrointestinal & Endocrine Pharmacology | |||
|---|---|---|---|
| Drug Class | Prototype Drugs | Target & Mechanism of Action | High-Yield Exam Pearl |
| Proton Pump Inhibitors (PPIs) | Omeprazole, Pantoprazole, Esomeprazole, Rabeprazole | Prodrugs converted to sulfenamide → irreversibly bind and inactivate H+/K+-ATPase proton pump in parietal cells. | Most potent acid suppressants. Must be taken 30-60 minutes before meals on an empty stomach. |
| H2 Receptor Antagonists | Ranitidine, Famotidine, Cimetidine | Competitive antagonism of histamine H2 receptors on basolateral membrane of gastric parietal cells. | Cimetidine inhibits cytochrome P450 enzymes and possesses antiandrogenic effects (gynecomastia). |
| Biguanides (Antidiabetic) | Metformin | Activates AMP-activated protein kinase (AMPK) → suppresses hepatic gluconeogenesis and increases peripheral glucose uptake. | First-line drug in Type-2 Diabetes Mellitus. Does NOT cause hypoglycemia or weight gain. Rare severe risk: Lactic acidosis. |
| Sulfonylureas (Secretagogues) | Glimepiride, Gliclazide, Glibenclamide | Block ATP-sensitive K+ channels (K-ATP) on pancreatic beta cells → depolarization → Ca2+ influx → exocytosis of insulin. | Major side effect is hypoglycemia and weight gain. Requires functional pancreatic beta cells to exert effect. |
| Useful Important Links & Official References | |
|---|---|
| Drugs & Cosmetics Act 1940 & Rules 1945 Schedules Master Guide (A to Y) | Click Here |
| Pharmaceutics Posology Formulas, Proof Spirit & Calculations Master Guide | Click Here |
| Hospital & Clinical Pharmacy Notes: Cold Chain Temperatures & ADRs | Click Here |
| Download High-Yield Revision Notes (Antidotes & D&C Schedules) | Click Here |
| Railway RRB Pharmacist Previous Year CBT Solved Paper | Click Here |
| ESIC Pharmacist Solved Question Paper with Official Answer Key | Click Here |
| AIIMS CRE Pharmacist Grade-II CBT Solved Question Paper | Click Here |
| Official Pharmacy Council of India (PCI) Portal | Click Here |
| Indian Pharmacopoeia Commission (IPC Ghaziabad) | Click Here |
| Sarkari Pharma Official Homepage (All Updates) | Click Here |
Frequently Asked Questions (FAQ)
Q: Are these Pharmacology notes enough for government pharmacist exam preparation?
A: These notes are designed as revision aids and cover high-yield exam topics. For thorough preparation, supplement them with standard pharmacy textbooks and previous year question papers.
Q: Which exams can I use these notes for?
A: These notes are useful for all government pharmacist exams including ESIC, RRB, AIIMS, CGHS, DSSSB, UPSSSC, and various state-level NHM pharmacist exams.
Q: Are these notes updated for 2026 syllabus?
A: Yes. The content is aligned with the current D.Pharm and B.Pharm curriculum and government pharmacist exam patterns for 2026.
Q: Can I download these notes as a PDF?
A: Yes. Use the download link provided at the end of the page to save the notes for offline revision.